Skip to main content

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Featured Article: N6-methyladenosine modification—a key player in viral infection

New Content Item

In this review article, the role of m6A modifications in viral replication and virus–host interactions are examined. In particular, the authors focus on DNA and RNA viruses associated with human diseases including acute SARS-CoV-2, HIV-1, Epstein–Barr virus, and KSHV. The article aims to contribute to the understanding of the mechanisms of virus–host interactions and the design of future therapeutic targets for treatment of tumor associated with viral                                                                                                       infections.

Call For Papers

CMBL is currently commissioning a new special collection on Gene regulation tools for treating genetic diseases and cancers based on CRISPR-related technologies. Guest Edited by Yuchen Liu, we welcome the submission of reviews and primary research articles that examine CRISPR-related technologies which have emerged as powerful tools for editing and manipulating genes, and have revolutionized the field of gene therapy. This Collection aims to highlight the latest research and developments in this field, with a focus on the regulatory tools used to treat genetic diseases and cancers.

Submission Deadline: December 31, 2023

Aims and scope

Cellular & Molecular Biology Letters is an international journal dedicated to the dissemination of fundamental knowledge in all areas of cellular and molecular biology, cancer cell biology, and certain aspects of biochemistry, biophysics and biotechnology.

Read more


Aleksander Sikorski, University of Wrocław, Poland

Reviewer Acknowledgements

Please visit the Cellular and Molecular Biology Letters society website and click on "Acknowledgements to Referees" and the year you wish to search to view current and past reviewers

Archival content

Cellular & Molecular Biology Letters was founded in 1996 and transferred to BioMed Central in 2016. Previously, its publishers were Walter De Gruyter in 2015 (content available from De Gruyter's archive), and Springer from 2006–2014 (content available from BMC web page). Articles published between 1996 and 2005 can be found at the CMBL home page, on the Volume List tab. To request free electronic versions of these articles, please contact

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    8.3 - 2-year Impact Factor
    7.2 - 5-year Impact Factor
    1.573 - SNIP (Source Normalized Impact per Paper)
    1.643 - SJR (SCImago Journal Rank)

    2022 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    104 days submission to accept (Median)

    2022 Usage 
    770 Altmetric mentions